Aureka Biotechnologies, Inc.
Aureka Biotechnologies is a biotech startup dedicated to democratizing the pharmaceutical industry through integrated digital biology and AI solutions. Their mission is to improve human health by digitalizing and democratizing therapeutic discovery, aiming to significantly reduce costs and time, and enable novel treatments for challenging targets. They focus on high-throughput synthetic biology, single-cell functional screening, AI-based drug design, and autonomous evolution to accelerate therapeutic discovery. Their vision is to design high-value protein therapeutics at scale using a transformative, data-driven AI platform.
Industries
Nr. of Employees
small (1-50)
Aureka Biotechnologies, Inc.
Laguna Hills, California, United States, North America
Products
Rapid generation of potent antibodies by autonomous hypermutation in yeast (publication)
Scientific publication describing autonomous hypermutation in yeast as a method for rapid antibody generation and evolution.
A high throughput bispecific antibody discovery pipeline (publication)
Scientific publication describing a high-throughput pipeline for bispecific antibody discovery, including microfluidic methods.
Rapid generation of potent antibodies by autonomous hypermutation in yeast (publication)
Scientific publication describing autonomous hypermutation in yeast as a method for rapid antibody generation and evolution.
A high throughput bispecific antibody discovery pipeline (publication)
Scientific publication describing a high-throughput pipeline for bispecific antibody discovery, including microfluidic methods.
Services
Co-discovery and platform access for protein therapeutic design
Collaborative co-discovery engagements that provide partners access to an integrated digital-biology and AI platform to design and optimize protein therapeutics and difficult antibody targets.
Co-discovery and platform access for protein therapeutic design
Collaborative co-discovery engagements that provide partners access to an integrated digital-biology and AI platform to design and optimize protein therapeutics and difficult antibody targets.
Expertise Areas
- Digital biology and AI-driven therapeutic design
- High-throughput screening and single-cell assays
- Synthetic biology and directed evolution
- Antibody and protein therapeutic engineering
Key Technologies
- Single-cell functional screening
- High-throughput synthetic biology and library construction
- Autonomous directed evolution in yeast
- Microfluidics for antibody discovery